Sign up to save your podcasts
Or
Share First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer.
CME information and select publications here.
View all episodes
By Dr. Neil Love
4.9
5656 ratings
Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer.
CME information and select publications here.
More shows like Oncology Today with Dr Neil Love
View all
JAMA Editors' Summary
135 Listeners
NEJM This Week
318 Listeners
JAMA Clinical Reviews
493 Listeners
Breast Cancer Update
66 Listeners
Lung Cancer Update
31 Listeners
Hematologic Oncology Update
76 Listeners
Prostate Cancer Update
13 Listeners
Gastrointestinal Cancer Update
17 Listeners
Gynecologic Oncology Update
12 Listeners
Dermatologic Oncology Update
0 Listeners
Research To Practice | Oncology Videos
115 Listeners
ASCO Daily News
57 Listeners
The Curbsiders Internal Medicine Podcast
3,334 Listeners
The ONS Podcast
197 Listeners
ASCO Guidelines
44 Listeners
OncLive® On Air
22 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
364 Listeners
Two Onc Docs
189 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
43 Listeners
Oncology Nursing Update with Dr Neil Love: Focus on Oncology Nursing
0 Listeners